Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients.
Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights.
As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
The Canadian Patent Office (CIPO) has advised that as of January 14, 2025, it had granted patents for which final fees were processed in the old system.
Charles Boulakia’s articles from Smart & Biggar are most popular:
within Intellectual Property topic(s)
Smart & Biggar are most popular:
with readers working within the Pharmaceuticals & BioTech industries
The Canadian Patent Office (CIPO) has advised that as of January
14, 2025, it had granted patents for which final fees were
processed in the old system. CIPO has started to process
applications where final fees were paid in the Next Generation
Patents (NGP) system, and has started granting these patents. The
Canadian Patent Database will indicate the status of patents as
"Pre-grant", which means that the final fee payment has
been processed and determined compliant.
CIPO is temporarily publishing a List of
"Pre-grant" applications that indicates a predicted
grant date, with a new file posted weekly normally on Thursday.
CIPO has warned that this is not a guaranteed grant date, but if
not granted on the predicted date, the patent should be granted the
following week.
The preceding is intended as a timely update on Canadian
intellectual property and technology law. The content is
informational only and does not constitute legal or professional
advice. To obtain such advice, please communicate with our offices
directly.
